About ePatientFinder
ePatientFinder is a Healthcare company based in Austin (United States) founded in 2013, and was acquired by Elligo in May 2018. ePatientFinder has raised $14.88 million across 4 funding rounds from investors including LabCorp, Elligo and Allscripts. The company has 23 employees. Its chief executive, as recorded, is John Potthoff. ePatientFinder offers products and services including IntElligo Research Stack, Study Marketplace, and Patient Select Model. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Functional Services. Its competitors include Elligo, Acurian and Velocity Clinical Research; 2 of its 3 listed competitors have raised funding.
Company details
Clinical trial recruitment service company. The platform collects data from the providers EHR and uses it to match the providers patients with clinical trials and preventative procedures that recently received FDA clearance. Clients are the life sciences companies who want to accelerate recruiting for their clinical trials and provide a new way to market their new products.
- Headquarters Austin, United States
- Employees 23
- Stage Acquired
- SectorsHealthcare
- Website epatientfinder.com
- Social LinkedIn X Facebook
- Acquired by Elligo (May 2018)
Products & Services of ePatientFinder
ePatientFinder offers a comprehensive portfolio of products and services, including IntElligo Research Stack, Study Marketplace, and Patient Select Model.
Platform for managing clinical trials and data integration.
Technology for simplifying clinical trial site selection.
System to engage patients for clinical research trials.
Funding Insights of ePatientFinder
ePatientFinder has successfully raised a total of $14.88M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $2.6 million completed in September 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $14.88M
- Total Rounds 4
- Last Round Series B — $2.6M
- First Round $1.4M
(May 2014)
- Investors Count 2
All 4 funding rounds of ePatientFinder with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2017 | $2.6M | Series B | – | – | – |
| Jun 2016 | $8.3M | Series B | – | – | |
| Feb 2015 | $2.58M | Series A | – | – | – |
| May 2014 | $1.4M | Seed | – | – | – |
3 investors in total: 3 institutional.
Investors in ePatientFinder
ePatientFinder has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include LabCorp, Elligo and Allscripts.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Offers healthcare data analytics, tech platforms, and networks for providers and payers. | 1986 | allscripts.com | Chicago, United States | |
Provider of laboratory tests for physicians | 1969 | labcorp.com | Burlington, United States | |
Patient recruitment and site activation services are provided by Elligo. | 2016 | elligohealthresearch.com | Austin, United States |
Investor details for ePatientFinder
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ePatientFinder
1 people are tracked at ePatientFinder (1 in leadership); the tracked headcount is 23.
| Name | Role | Group |
|---|---|---|
John Potthoff | CEO | Leadership |
Complete people profiles for ePatientFinder
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of ePatientFinder
4 dated milestones of ePatientFinder across 5 years, from founding to its latest funding, stage changes and deals.
- Founded ePatientFinder is founded.
- Funding First funding round of $1.4M.
- Funding Latest funding round, Series B, of $2.6M.
- Exit Acquired by Elligo.
Competitors of ePatientFinder
ePatientFinder has 3 listed competitors in our database, 2 of them funded. They include Elligo, Acurian and Velocity Clinical Research.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| elligohealthresearch.com | 2016 | Austin, United States | $176.48M | 280 | Patient recruitment and site activation services are provided by Elligo. | |
| acurian.com | 1998 | Horsham, United States | $27M | Patient enrollment and retention solutions for clinical trials are offered. | ||
| velocityclinical.com | 2017 | Durham, United States | Provider of site management and patient recruitment services |
Detailed competitors of ePatientFinder
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ePatientFinder
Websites that share an audience with ePatientFinder (epatientfinder.com).
Websites whose visitors overlap most with ePatientFinder. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
epatientdave.com | epatientdave.com | 100% | #12,354,152 | – | |
e-patients.net | e-patients.net | 100% | – | ||
mdsol.com | mdsol.com | 98% | #86,144 | – |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as ePatientFinder (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Epatientfinder
Complete news archive for ePatientFinder
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ePatientFinder
ePatientFinder was founded in 2013 and raised its 1st funding round 1 year after it was founded.
ePatientFinder is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
John Potthoff is the CEO of ePatientFinder, as recorded in our data.
ePatientFinder is a funded company, having raised a total of $14.88M across 4 funding rounds to date. The company's 1st funding round was a Seed of $1.4M, raised on May 2014.
ePatientFinder has 23 employees.
Clinical trial recruitment service company. The platform collects data from the providers EHR and uses it to match the providers patients with clinical trials and preventative procedures that recently received FDA clearance. Clients are the life sciences companies who want to accelerate recruiting for their clinical trials and provide a new way to market their new products.
ePatientFinder's top competitors include Velocity Clinical Research, Elligo and Acurian.
ePatientFinder offers IntElligo Research Stack, Study Marketplace, and Patient Select Model.
ePatientFinder has 3 investors. Key investors include LabCorp, Elligo, and Allscripts.
Yes. ePatientFinder was acquired by Elligo in May 2018.